𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cisplatin-based chemotherapy: the only alternative in chemoradiation of head and neck cancer? Experience of the Institute of Oncology, Ljubljana, Slovenia

✍ Scribed by Primož Strojan

Publisher
Wielkopolskie Centrum Onkologii
Year
2007
Tongue
Polish
Weight
127 KB
Volume
12
Category
Article
ISSN
1507-1367

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cisplatin-based chemotherapy in advanced
Cisplatin-based chemotherapy in advanced adenoid cystic carcinoma of the head and neck
✍ L. De Dick Haan; Dr. Pieter H. M. De Mulder; Dr. Jan B. Vermorken; Dr. Jan H. Sc 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 488 KB 👁 2 views

Nineteen patients, nine men and 10 women, with advanced adenoid cystic carcinoma (ACC), were treated with cisplatin either alone or in combination with doxorubicin and bleomycin. Median age was 51 years (range: 32-73 years). Two groups of patients were distinguished: Group 1 (N = 10) received single

Docetaxel, cisplatin, and 5-fluorouracil
Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck : The Dana Farber Cancer Institute experience
✍ Robert Haddad; A. Dimitrios Colevas; Roy Tishler; Paul Busse; Laura Goguen; Chri 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 2 views

## Abstract ## BACKGROUND The authors conducted a series of four Phase I–II trials of high‐dose and intermediate‐dose docetaxel, cisplatin, and 5‐fluorouracil (TPF)‐based induction chemotherapy for patients with advanced squamous cell carcinoma of the head and neck (SCCHN). The chemotherapy regime

Cisplatin-based chemotherapy in advanced
Cisplatin-based chemotherapy in advanced seminoma: Experience of the Northern Israel Oncology Center: 1981–1994
✍ Stein, Moshe E.; Kuten, Abraham; Drumea, Keren; Moshkowitz, Boaz; Nativ, Ofer; M 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

## Background: The efficacy of cisplatinum combined chemotherapy modalities was investigated in a variety of trials for patients with advanced seminoma. results regarding remission rates and survival are encouraging. ## Methods: Between december 1981 and january 1994, 13 patients with either rela

Molecular markers predict outcome in squ
Molecular markers predict outcome in squamous cell carcinoma of the head and neck after concomitant cisplatin-based chemoradiation
✍ Guido B. van den Broek; Maarten Wildeman; Coen R.N. Rasch; Nicola Armstrong; Ed 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 141 KB 👁 1 views

## Abstract Not all patients with squamous cell carcinomas of the head and neck (HNSCC) benefit from concurrent cisplatin‐based chemoradiation, but reliable predictive markers for outcome after chemoradiation are scarce. We have investigated potential prognostic biomarkers for outcome in a large gr